Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients

Table 1

Clinical and demographic data for the study group.

		Patients’ number (%)
Gender	Men	27 (30.7%)
	Women	61 (69.3%)	0.000
Location	Urban	51 (59.3%)
	Rural	35 (40.7%)	.054
Hypertension	Stage 1	16 (18.28%)	.002^a
	Stage 2	42 (47.72%)	.03^b
	Stage 3	30 (34%)	.000^c
Additional CV risk	Very high	33 (38.4%)	.04^d
	High	38 (44.2%)	.000^e
	Moderate	15 (17.4%)	.002^f
Controlled hypertension	No	30 (34.5%)
	Yes	57 (65.5%)	.000^g
Dyslipidemia	Without	8 (9.3%)
	Hypercholesterolemia	46 (53.5%)
	Mixed	27 (31.4%)
	Hypertriglyceridemia	5 (5.8%)
Smoking	No	67 (77.9%)
	Yes	19 (22.1%)	.001^g
Weight status	Normal	34 (39.5%)	.04^h
	Overweight	31 (27%)	.45^i
	Obese	21 (24.4%)	.03^j
Diabetes	Absent	56 (65.1%)
	Present	30 (34.9%)	.001^k

^aStage 1 versus stage 2; ^bstage 2 versus stage 3; ^cstage 1 versus stage 3; ^dvery high versus high; ^ehigh versus moderate; ^fvery high versus moderate; ^gno versus yes; ^hnormal versus overweight; ⁱoverweight versus obese; ^jnormal versus obese; ^kpresent versus absent. CV: cardiovascular.